Davies Collison Cave
In the current COVID-19 environment, much of the innovation that we will require to tackle this pandemic will be borrowed from innovations of the past.
Substantial investment is needed to get a drug to market, with development costs averaging in excess of nearly US$2.8 billion, and more than 85% of drugs fail in clinical trials.
Smart & Biggar
On March 30, 2020, Kennedy and Janssen applied to the Supreme Court of Canada for leave to appeal a Federal Court of Appeal decision relating to Kennedy's patent covering uses of REMICADE...
Smart & Biggar
On April 8, 2020, the Federal Court of Appeal (FCA) released a decision finding that the Federal Court Notice to the Profession re: Experimental Testing (Notice) does not apply to pre-litigation...
Bereskin & Parr LLP
McCartney & Lennon, Watson & Crick, Mary & Pierre Curie. We are all looking for synergistic collaborations.
Norton Rose Fulbright Canada LLP
Santé Canada et le Bureau de la concurrence se sont empressés de publier des déclarations indiquant qu'ils continueraient à surveiller le marché pour lutter contre les activités...
McCarthy Tétrault LLP
On May 6, 2011, the CBSA issued Customs Notice 20-19 (the "Customs Notice"), which includes information on the Certain Goods Remission Order (COVID-19), SOR-2020-101 (the "Order") under the Customs Tariff.
Many Canadian import businesses have implemented remote working arrangements for employees as a result of COVID-19 government directives at the federal, provincial and municipal levels.
Bereskin & Parr LLP
Many life sciences companies have been willing to permit others to access their IP to help increase supply of equipment and development of new treatments during the COVID-19 pandemic.
Campbells acted as Cayman Islands and British Virgin Islands legal counsel for Peijia Medical Limited ("Peijia Medical") on the second largest IPO on the Hong Kong Stock Exchange this year
Global Advertising Lawyers Alliance (GALA)
As the direct impact of COVID-19 in China gradually subsides, the government has released the 2020 legislation plans and the working report for the first quarter of 2020.
G. Vrikis & Associates LLC
Following the issue of Regulations ΚΔΠ 5229-5233 and ΚΔΠ 5239, the Minister of Labour, Welfare and Social Insurance issued on 2nd May 2020 Regulations ΚΔΠ 5257-5261 extending the provision of Special Leave Benefit...
Arnold & Porter
This is the month when it was all due to happen: after years of planning and preparing, the MDR was finally due to take effect on 26 May 2020.
This week, we take a closer look at issues relating to the supply and use of personal protective equipment ("PPE") in the context of the response to the COVID-19 crisis. The coronavirus outbreak continues to have...
A l'heure où de nombreux laboratoires dans le monde se mobilisent pour la recherche d'un traitement contre le covid-19, où les essais cliniques se multiplient...
The European Commission recently issued COVID-19-related guidance (see Jones Day Alert, March 2020), ahead of the entry into force of the new EU FDI screening mechanism in October 2020. Several member states have been tightening ...
P+P Pöllath + Partners
On 20 May 2020, the German federal government passed into law the 15th Ordinance amending the Foreign Trade Ordinance (the 15th FTO Amendment).
Before any rules were notified for medical devices, they were being governed solely by the dated and redundant Drugs and Cosmetics Act, 1940 with no specific provisions or aspects pertaining to the regulation of medical devices in India.
The Law on the Introduction of Amendments to Certain RF Laws Concerning the Prevention and Liquidation of Emergency Situations has now come into force,...